Assessment of cardiometabolic risk associated with overweight, based on the use of the Aterostop calculator

Abstract

Objective: to assess the cardiometabolic risk associated with overweight and obesity by using the Aterostop calculator to determine cardiovascular risk.
Materials and methods: in a cross-section study of 456 practically healthy individuals and patients with established atherosclerotic CVD, we were assessed the cardiometabolic risk associated with overweight and obesity using the Aterostop calculator.
Results: in the whole group, overweight and obesity were observed in ⅔ subjects; obesity was in 27.4%. In contrast to men, the proportion of women with an increase in BMI progressively increased. With increasing age, BMI increased only in women. We found a significant increase in BMI in the presence of CHD, high BP and DM, as well as a tendency to a higher BMI in smokers. The proportion of obese individuals increased markedly as cardiovascular risk increased among both men and women. Overweight and obese individuals had combined hyperlipidemia (increased both TC and TG), and statin therapy contributed to
a significant decrease in plasma cholesterol and LDL.
Conclusion: the results obtained with the Atherostop calculator indicate a high prevalence of overweight in the Russian population, especially in women. An increase in BMI is associated with the presence of CHD, hypertension and diabetes. Statin therapy significantly reduces the levels of TC and LDL cholesterol in overweight individuals, but a more aggressive approach is required to achieve the target lipid levels.